Privia Health Net Profit Margin 2020-2023 | PRVA

Privia Health net profit margin from 2020 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Privia Health Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $1.66B $0.02B 1.39%
2023-09-30 $1.58B $0.04B 2.41%
2023-06-30 $1.51B $0.03B 2.26%
2023-03-31 $1.43B $0.02B 1.19%
2022-12-31 $1.36B $-0.01B -0.59%
2022-09-30 $1.27B $-0.04B -3.00%
2022-06-30 $1.18B $-0.05B -4.16%
2022-03-31 $1.07B $-0.21B -19.87%
2021-12-31 $0.97B $-0.19B -19.54%
2021-09-30 $0.91B $-0.17B -19.09%
2021-06-30 $0.86B $-0.15B -17.07%
2021-03-31 $0.82B $0.03B 3.79%
2020-12-31 $0.82B $0.03B 3.79%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.139B $1.658B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.723B 19.61
Inspire Medical Systems (INSP) United States $7.393B 0.00
IRhythm Technologies (IRTC) United States $3.477B 0.00
Axonics (AXNX) United States $3.412B 0.00
10x Genomics (TXG) United States $3.208B 0.00
Enovis (ENOV) United States $3.038B 23.08
Azenta (AZTA) United States $2.905B 236.82
Olink Holding AB (publ) (OLK) Sweden $2.820B 0.00
Hims & Hers Health (HIMS) United States $2.680B 0.00
Schrodinger (SDGR) United States $1.827B 0.00
Omnicell (OMCL) United States $1.248B 30.53
Phreesia (PHR) United States $1.185B 0.00
Definitive Healthcare (DH) United States $0.821B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.680B 0.00
Fulgent Genetics (FLGT) United States $0.619B 0.00
Talkspace (TALK) United States $0.536B 0.00
Health Catalyst (HCAT) United States $0.373B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.329B 0.00
Clover Health Investments (CLOV) United States $0.318B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
P3 Health Partners (PIII) United States $0.183B 0.00
Butterfly Network (BFLY) United States $0.164B 0.00
American Well (AMWL) United States $0.154B 0.00
Outset Medical (OM) United States $0.147B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
Augmedix (AUGX) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.04
111 (YI) China $0.088B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.048B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00